Sabine Mueller, MD, Ph.D., MAS is the Co-Founder and Project Lead of PNOC and Professor
of Neurology, Neurosurgery and Pediatrics at University of California, San Francisco (UCSF)
and Affiliated Professor at the University of Zurich, Switzerland. She is a pediatric neuro-
oncologist who specializes in the care of children with brain tumors. Mueller leads the pediatric
brain tumor program at UCSF and serves as one of the leads of the pediatric malignancy program
of the UCSF Helen Diller Comprehensive Cancer Center. Prior to completing medical school,
she served as a scientist, director of genomics, and project leader for the brain tumor program at
AGY Therapeutics, a biotechnology company in South San Francisco. Dr. Mueller earned her
PhD and MD degrees from the University of Hamburg, Germany, and furthered her medical
training at Harvard University and UCSF. She is board-certified in pediatrics, neurology with
focus on child neurology, and neuro-oncology. In her research, Dr. Mueller focuses on
developing new therapeutic approaches for children with brain tumors with a specific interest in
diffuse midline glioma, as well as improving long-term cognitive outcomes. She currently leads
PNOC – an international clinical trial consortium with 22 sites in the US as well as sites in
Switzerland, Netherlands, Israel, Australia, Egypt and India – and serves as the medical lead of
the diffuse midline glioma center in Zurich, Switzerland. Recently, Dr. Mueller also joined the
Childhood Brain Tumor Network as one of the executive chairs and is an affiliated group leader
at the Princess Maxima Center in the Netherlands. She has received multiple grants, including
funding from the Department of Defense and the National Cancer Institute.
